Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.

Transfusion - 1 May 2022

Gajic-Veljanoski Olga, Li Chunmei, Schaink Alexis K, Guo Jennifer, Shehata Nadine, Charames George S, de Vrijer Barbra, Clarke Gwen, Pechlivanoglou Petros, Okun Nanette, Kandel Rita, Dooley Joseph, Higgins Caroline, Ng Vivian, Sikich Nancy

Abstract excerpt

BACKGROUND: We sought to determine the cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies in Canada. STUDY DESIGN AND METHODS: We developed two probabilistic state-transition (Markov) microsimulation models to compare fetal genotyping followed by targeted management versus usual care (i.e., universal Rh immunoglobulin [RhIG] prophylaxis in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Group Antigens
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fetal Blood

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 35170037
DOI: 10.1111/trf.16826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.PMID 35170037Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.Semantic proximity Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.Semantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotypeSemantic proximity Read ↗

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.Semantic proximity Read ↗

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.Semantic proximity Read ↗

Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical ConsiderationsSemantic proximity Read ↗

Cell-free DNA analysis for the determination of fetal red blood cell antigen genotype in alloimmunized pregnanciesSemantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.